TRIM21 and steatosis: Collectively, these studies support a model whereby high levels of TRIM21 in the liver act as a counterregulatory force of steatosis development by regulating critical transcriptional and posttranscriptional factors as well as enzymes of DNL but also induce an inflammatory response that is independent of A1CF degradation.